BidaskClub lowered shares of Cardiovascular Systems (NASDAQ:CSII) from a buy rating to a hold rating in a research note published on Friday, March 16th.
CSII has been the subject of a number of other reports. Zacks Investment Research downgraded Cardiovascular Systems from a buy rating to a hold rating in a research report on Monday, February 12th. Raymond James Financial reaffirmed a hold rating on shares of Cardiovascular Systems in a report on Monday, December 4th. Needham & Company LLC cut Cardiovascular Systems from a buy rating to a hold rating and reduced their price objective for the company from $33.11 to $23.00 in a research note on Friday, December 15th. Leerink Swann reduced their price objective on Cardiovascular Systems from $31.00 to $30.00 and set an outperform rating for the company in a research note on Thursday, February 8th. Finally, ValuEngine cut Cardiovascular Systems from a hold rating to a sell rating in a research note on Friday, February 2nd. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company. The stock presently has a consensus rating of Hold and a consensus target price of $27.00.
Shares of NASDAQ CSII traded down $0.33 during trading on Friday, hitting $22.87. 153,080 shares of the company were exchanged, compared to its average volume of 242,377. The firm has a market cap of $770.66, a PE ratio of 762.33 and a beta of 2.15. Cardiovascular Systems has a 12-month low of $20.58 and a 12-month high of $33.11. The company has a quick ratio of 4.13, a current ratio of 4.65 and a debt-to-equity ratio of 0.17.
Cardiovascular Systems (NASDAQ:CSII) last released its earnings results on Wednesday, February 7th. The medical device company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.03. Cardiovascular Systems had a negative return on equity of 0.50% and a negative net margin of 1.62%. The company had revenue of $52.63 million during the quarter, compared to the consensus estimate of $53.39 million. During the same period in the previous year, the company posted $0.03 EPS. Cardiovascular Systems’s revenue was up 5.2% compared to the same quarter last year. research analysts expect that Cardiovascular Systems will post -0.07 EPS for the current year.
A number of institutional investors have recently bought and sold shares of CSII. State Street Corp grew its holdings in Cardiovascular Systems by 0.9% in the second quarter. State Street Corp now owns 677,462 shares of the medical device company’s stock valued at $21,828,000 after purchasing an additional 6,074 shares during the last quarter. The Manufacturers Life Insurance Company boosted its stake in shares of Cardiovascular Systems by 1.2% during the second quarter. The Manufacturers Life Insurance Company now owns 25,114 shares of the medical device company’s stock valued at $809,000 after acquiring an additional 299 shares during the last quarter. Jennison Associates LLC boosted its stake in shares of Cardiovascular Systems by 80.2% during the third quarter. Jennison Associates LLC now owns 22,647 shares of the medical device company’s stock valued at $638,000 after acquiring an additional 10,080 shares during the last quarter. New York State Common Retirement Fund lifted its position in Cardiovascular Systems by 4.9% during the third quarter. New York State Common Retirement Fund now owns 464,811 shares of the medical device company’s stock worth $13,084,000 after buying an additional 21,507 shares during the period. Finally, Cortina Asset Management LLC lifted its position in Cardiovascular Systems by 5.0% during the third quarter. Cortina Asset Management LLC now owns 872,363 shares of the medical device company’s stock worth $24,557,000 after buying an additional 41,496 shares during the period. 82.55% of the stock is currently owned by institutional investors.
WARNING: This report was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another website, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this report can be accessed at https://www.dispatchtribunal.com/2018/04/07/cardiovascular-systems-csii-lowered-to-hold-at-bidaskclub.html.
Cardiovascular Systems Company Profile
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.